Improving diagnostics to protect
INDICAL is a leader in molecular diagnostics for vet-specific applications. We provide solutions for diagnostic workflows, the protocols for their use, and the support that empowers our customers every day.
With a rich history beginning in 1996 as Labor Diagnostik Leipzig (LDL), we have established ourselves as an innovative, reliable, and forward-thinking laboratory and diagnostic solution provider – serving and working closely with private and state diagnostic laboratories around the world.
As of 2018, INDICAL is an independent company with renewed focus and ambition to achieve our mission: Improving diagnostics to protect animal and human health together.
To get there, we provide our customers with complete workflow solutions within molecular diagnostics and next generation sequencing – focusing on vet applications and the broader food value chain with a One Health agenda.
A partnership focused on improving diagnostics
The 2012 acquisition of LDL by QIAGEN, a leader in molecular diagnostics and life sciences, proved our successes and strengthened our capabilities, with a strategic partnership beginning in 2018 and continuing into the future.
The combination of INDICAL’s expertise and state-of-the-art technology platform for developing vet specific applications, together with QIAGEN’s capabilities, enables us to serve our customers with a suite of industry-leading diagnostic portfolios.
Through our strategic partnership with QIAGEN, we will drive innovation together, with customers, to improve diagnostics.